AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 89 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,922,352 | -29.8% | 1,448,772 | +12.4% | 0.29% | -32.0% |
Q2 2023 | $21,245,933 | +60.6% | 1,289,195 | -10.8% | 0.43% | +52.3% |
Q1 2023 | $13,232,856 | +11.7% | 1,444,635 | -12.7% | 0.28% | -15.4% |
Q4 2022 | $11,851,661 | -12.4% | 1,655,260 | -38.7% | 0.33% | -6.2% |
Q3 2022 | $13,526,000 | +52.6% | 2,699,795 | -25.7% | 0.35% | +63.9% |
Q2 2022 | $8,862,000 | -56.6% | 3,631,475 | +21.5% | 0.22% | -50.6% |
Q1 2022 | $20,413,000 | -2.8% | 2,988,675 | +15.0% | 0.44% | -4.6% |
Q4 2021 | $21,006,000 | -34.0% | 2,599,634 | -19.9% | 0.46% | -33.7% |
Q3 2021 | $31,824,000 | +45.9% | 3,247,286 | +0.2% | 0.69% | +42.5% |
Q2 2021 | $21,806,000 | -16.2% | 3,240,011 | +10.4% | 0.48% | -21.3% |
Q1 2021 | $26,027,000 | +31.3% | 2,934,241 | -0.9% | 0.62% | +20.8% |
Q4 2020 | $19,815,000 | +38.4% | 2,961,878 | +4.3% | 0.51% | +3.0% |
Q3 2020 | $14,317,000 | +19.4% | 2,840,669 | +91.5% | 0.50% | +35.6% |
Q2 2020 | $11,988,000 | -7.9% | 1,483,627 | -9.5% | 0.36% | -19.8% |
Q1 2020 | $13,012,000 | -52.8% | 1,638,838 | -55.1% | 0.46% | -30.6% |
Q4 2019 | $27,571,000 | +7.2% | 3,651,948 | -40.9% | 0.66% | -1.4% |
Q3 2019 | $25,721,000 | +31.2% | 6,182,836 | -8.9% | 0.66% | +52.2% |
Q2 2019 | $19,608,000 | +93.0% | 6,784,790 | -3.8% | 0.44% | +85.2% |
Q1 2019 | $10,157,000 | -44.7% | 7,052,720 | -0.9% | 0.24% | -49.6% |
Q4 2018 | $18,367,000 | -34.0% | 7,119,054 | +12.4% | 0.47% | -25.5% |
Q3 2018 | $27,813,000 | -8.7% | 6,335,548 | +27.5% | 0.63% | -8.6% |
Q2 2018 | $30,467,000 | -13.1% | 4,970,106 | +3.4% | 0.69% | -8.2% |
Q1 2018 | $35,054,000 | +29.2% | 4,808,493 | +45.3% | 0.75% | +36.5% |
Q4 2017 | $27,128,000 | – | 3,308,250 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |